EichorEICHOR
Condition: Soft Tissue Cancer Synced from ClinicalTrials.gov · August 08, 2026

Recruiting studies: Soft Tissue Cancer

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Phase I Trial of Memory T Cells Expressing an NKG2D Chimeric Antigen Receptor in Children, Adolescents and Young Adult
Phase 1 · 1 location(s) · Antonio Pérez Martínez · NCT06087341Minibeam Radiation Therapy With Tungsten Slit Collimator for the Treatment of Recurrent or Metastatic Skin or Soft Tissu
NA · 1 location(s) · Mayo Clinic · NCT07062003A Phase II Trial of Tebentafusp in HLA-A*02:01 Positive Patients With Advanced Clear Cell Sarcoma
Phase 2 · 2 location(s) · Sarcoma Alliance for Research through Collaboration · NCT06942442Atezolizumab and Cabozantinib for the Treatment of Adolescents and Young Adults With Recurrent or Metastatic Osteosarcom
Phase 2 · 2 location(s) · M.D. Anderson Cancer Center · NCT05019703"Ultra-High Frequency intraOral UltraSonography of the TONgue" (HOUSTON)
NA · 1 location(s) · University of Pisa · NCT06336941Trilaciclib Combing Chemotherapy in the Neoadjuvant Treatment of Osteosarcoma
Phase 2 · 1 location(s) · Peking University People's Hospital · NCT06714383Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
Phase N/A · 8 location(s) · AIDS Malignancy Consortium · NCT05663502Assessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote Monitoring
Phase 2 · 3 location(s) · Centre Oscar Lambret · NCT05500391An Open-Label Study to Evaluate the Effect of Elix Cycle Balance & Elix Daily Harmony on Fibroid-related Symptoms
NA · 1 location(s) · Zenchi, Inc. · NCT07078682Assessment of Tubal Occlusion During Minimally Invasive Myomectomy
NA · 1 location(s) · Medstar Health Research Institute · NCT06988774Early Phase Study Evaluating MEK and MDM2 Inhibition in Patients With NF1 and MPNST
Phase 1/Phase 2 · 2 location(s) · AeRang Kim · NCT06735820Safety and Efficacy of DIT309 in Advanced Bone and Soft Tissue Sarcomas
Phase 1 · 1 location(s) · Tcelltech Inc. · NCT07052383GIST Oral Paclitaxel(Liporaxel)
Phase 2 · 1 location(s) · Asan Medical Center · NCT06326346Precision Imaging to Evaluate Kaposi Sarcoma
NA · 2 location(s) · Washington University School of Medicine · NCT06898203Real-World Study of DLBCL With Different Genetic Subtypes
Phase N/A · 1 location(s) · Ruijin Hospital · NCT06026488Proton or Photon RT for Retroperitoneal Sarcomas
Phase 1/Phase 2 · 10 location(s) · Massachusetts General Hospital · NCT01659203Cirtuvivint in Selected Advanced Soft-Tissue Sarcomas
Phase 2 · 1 location(s) · Asociación Europea y Latinoamericana SELNET para la Investig · NCT07032285Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base Tumors
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT06176989Triplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors
Phase 1/Phase 2 · 1 location(s) · Second Affiliated Hospital of Guangzhou Medical University · NCT05187338Post-Exablate Pregnancy Outcomes Registry Study: Exablate Treatment of Symptomatic Uterine Fibroids
Phase N/A · 6 location(s) · InSightec · NCT05386615A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Phase 2/Phase 3 · 202 location(s) · National Cancer Institute (NCI) · NCT05691478Observational Study on Skeletal Ewing's Sarcoma
Phase N/A · 19 location(s) · Italian Sarcoma Group · NCT04845893Losartan + Sunitinib in Treatment of Osteosarcoma
Phase 1 · 4 location(s) · University of Colorado, Denver · NCT03900793Beliefs, Attitudes, and Response to Genetic Testing in SarcomaPatients
Phase N/A · 1 location(s) · University of Utah · NCT06875700A Long-term Study Evaluating Hepatotoxicity Associated With TURALIO™ (Pexidartinib) Treatment
Phase N/A · 8 location(s) · Daiichi Sankyo · NCT04635111Fluorescent Intra-operative Tumor Margin Examination
Phase 2 · 1 location(s) · Kurt Weiss · NCT04719156A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With Advanced Malignancies
Phase 1/Phase 2 · 28 location(s) · Deciphera Pharmaceuticals, LLC · NCT05957367Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
Phase 1 · 3 location(s) · BioEclipse Therapeutics · NCT04282044International Rare Brain Tumor Registry
Phase N/A · 13 location(s) · Children's National Research Institute · NCT05697874Descriptive Analysis of Surgeries in Patients With Multiple Osteochondromas
Phase N/A · 1 location(s) · Istituto Ortopedico Rizzoli · NCT07556874
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.